Key facts
- This page summarizes Oded Levy's Form 4 filing for Cardio Diagnostics Holdings, Inc. (CDIO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Jul 2023, 13:04.
Oded Levy - 30 Jun 2023 Form 4 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)
- Reporting relationship
- Director
- Issuer ticker
- CDIO
- Reported as of
- 30 Jun 2023
- Net transaction value
- +$50,000
- SEC form
- 4
- Accepted by SEC
- 05 Jul 2023, 13:04:26 UTC
- Prior SEC filing
- 21 Jun 2023
- Next SEC filing
- 04 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elisa Luqman as attorney-in-fact for Oded Levy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Oded Levy filed Form 4 for Cardio Diagnostics Holdings, Inc. (CDIO) on 05 Jul 2023.
Change
- Previous filing in this sequence was filed on 21 Jun 2023.
- Current net transaction value: +$50,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDIO
transaction
Common Stock
Options Exercise
- Transaction value
- $25,000
- Shares
- +21,008
- Change %
- Price
- $1.19
- Shares after
- 21,008
- Date
- 30 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDIO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $25,000
- Shares
- Change %
- Price
- Shares after
- $25,000
- Date
- 30 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- $25,000
- Exercise price
- $0.000000
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents the settlement of restricted stock units (RSUs) that vested on June 30, 2023 through the issuance of shares of Common Stock.
Footnote F2
Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On June 30, 2023, $25,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.
Footnote F3
On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.
Footnote F4
The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.